sitting on paper of over $25m is fine with me, in fact I'm overjoyed as it means wealth is being generated and anyone on board from 2012 or thereabouts is probably enjoying the benefits too. All I ask is please don't let this paper wealth (of our executive team) trick minds into wandering too far away, from the evolution they are leading. this is a critical juncture in A2M's leap towards being a global brand.
- Forums
- ASX - By Stock
- A2M
- Ann: Appendix 3B
Ann: Appendix 3B, page-8
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.82 |
Change
-0.100(2.03%) |
Mkt cap ! $3.489B |
Open | High | Low | Value | Volume |
$4.95 | $4.95 | $4.77 | $31.51M | 6.542M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 3831 | $4.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.82 | 252136 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 3831 | 4.810 |
2 | 4260 | 4.800 |
2 | 6100 | 4.790 |
5 | 31763 | 4.780 |
4 | 29250 | 4.770 |
Price($) | Vol. | No. |
---|---|---|
4.820 | 252136 | 2 |
4.830 | 25742 | 4 |
4.840 | 5000 | 1 |
4.850 | 268495 | 4 |
4.860 | 118035 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online